SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹154 Cr | ₹105 Cr | ₹79 Cr | ₹62 Cr | ₹8.21 Cr |
What is the latest Profit & Loss Account Balance ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2025 | ₹154 Cr |
| Mar2024 | ₹105 Cr |
| Mar2023 | ₹79 Cr |
| Mar2022 | ₹62 Cr |
| Mar2017 | ₹8.21 Cr |
How is Profit & Loss Account Balance of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2025 | ₹154 Cr | 47.23 | |
| Mar2024 | ₹105 Cr | 31.90 | |
| Mar2023 | ₹79 Cr | 27.77 | |
| Mar2022 | ₹62 Cr | 656.17 | |
| Mar2017 | ₹8.21 Cr | - | |
Compare Profit & Loss Account Balance of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,404.4 Cr | -1.1% | -9% | -36.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,536.0 Cr | 0.1% | 4.3% | -1.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,753.0 Cr | -0.6% | -1.3% | 5.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,650.0 Cr | 0.5% | -0.6% | 13.7% | Stock Analytics | |
| CIPLA | ₹122,143.0 Cr | -0.6% | -0.5% | 1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,244.0 Cr | -0.2% | 3.6% | -0.3% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | -1.1% |
-9% |
-36.5% |
| SENSEX | -0.5% |
1.1% |
3.8% |
You may also like the below Video Courses